Breaking
Sunday, June 14, 2026

Clinical Trials

🇺🇸 FDA Page 10

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.

Showing 109–120 of 380 articles

High impact AnalysisJun 2, 2026

Eli Lilly Dominates Pharma R&D Performance Rankings, Setting New Benchmarks

FDA · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Wave Life Sciences' Monthly Dosing Strategy for AATD: A Competitive Analysis

FDA · AATD · 10 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

DCAT Week 2024: Strategic Imperatives for Pharma BD and Investors

FDA · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

FDA Cracks Down on Illegal Tobacco Products Disguised as Everyday Items

FDA · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Supreme Court Upholds Medicare Drug Price Negotiation: Implications for Pharma

FDA · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Retro Biosciences Secures $1.8 Billion Valuation in Landmark Longevity Funding Round

FDA · longevity · 10 min

Dr. Sarah Mitchell
High impact NewsJun 2, 2026

Legend Biotech Presents Promising CARVYKTI and LB2102 Data at ASCO

7 min

Dr. Sarah Mitchell
High impact NewsJun 2, 2026

CDC Prioritizes Ebola Containment, Highlighting Critical Role of Clinical Trials

CDC · Ebola · 9 min

Dr. Sarah Mitchell
High impact AnalysisJun 1, 2026

: Eli Lilly Leads Pharma R&D Rankings: Insights and Implications

FDA · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 1, 2026

UCB's Bimzelx Triumphs Over AbbVie's Skyrizi in Psoriatic Arthritis

FDA · psoriatic arthritis · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 1, 2026

How to Use openFDA and FAERS Data Without Misreading Safety Signals

FDA · 6 min

Dr. Sarah Mitchell
High impact NewsJun 1, 2026

Formycon AG Geschäftsbericht 2025: Key Insights and Implications

FDA · 7 min

Dr. Sarah Mitchell